Scabies Treatment Market By Drug type (Sulphur Ointment, Benzyl Benzoate Lotion, Lindane Lotion, Crotamiton Cream, Permethrin Cream, Others), route of administration (Oral, Topical), Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography (North America, Latin America, Europe, Middle East and Africa, Asia Pacific)

 

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

 Scabies Treatment Market size is expected to be USD 212.24 million in 2022 to more than USD 322 million by 2028, growing at a high CAGR of 5.1% from 2022 to 2028. Scabies is a contagious skin infection caused by Sarcoptes scabiei. Pimple-like rashes and severe itchiness are the symptoms associated with scabies. The mode of transmission of scabies is skin-to-skin contact. The common site of infestation include armpits, around fingernails, inner elbow, in between fingers, and soles of feet among others. Scabies can be treated with antibiotics, antihistamines, and steroid creams. The Scabies Treatment Market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). This report on the global market gives historical, current, and future market sizes (US$ Bn) of drug type (sulfur ointment, benzyl benzoate lotion, lindane lotion, crotamiton cream, permethrin cream, others), route of administration (oral, topical), distribution channel and geographic regions. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, the market report includes a regulatory scenario and competition analysis with a vividly illustrated competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policymakers engaged in manufacturing and supply.

   

Scabies Treatment Market Summary

Study Period

2023-29

Base Year

2022

CAGR

5.1%

Largest Market

North America

Fastest Growing Market

Europe
Scabies Treatment Market Drivers and Restraints

Improper hygienic conditions and environmental factors are the key factor to increase the number of person affected to scabies. Moreover, low cost of drugs, increase in R&D for the innovation of newer drugs, rapid escalation of global population with poor hygienic, and increase in healthcare expenditure are anticipated to fuel the scabies treatment market. Moreover, homecare remedies for the scabies treatment and limited number of advanced therapeutics are expected to restrain the growth of scabies treatment market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Scabies Treatment Market Segmentation

Drug Type
  • Sulphur Ointment
  • Benzyl Benzoate Lotion
  • Lindane Lotion
  • Crotamiton Cream
  • Permethrin Cream
  • Others
Route-Administration
  • Oral
  • Topical
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Geography
  • North America
  • Latin America
  • Europe
  • Middle East and Africa
  • Asia Pacific

Frequently Asked Questions

The scabies treatment market is projected to expand at a CAGR of 5.1% during the forecast period

Merck & Co. Inc. (U.S.), Renaissance Pharma, Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), GlaxoSmithKline plc (U.K.), Unichem Laboratories Ltd. (India), Zydus Cadila (India), Prestium Pharma, Inc. (U.S.)

North America is the fastest-growing region for the home infusion therapy devices market

[urltag url='request-table-of-content']

  • Merck & Co. Inc. (U.S.)
  • Renaissance Pharma, Inc. (U.S.)
  • Sun Pharmaceutical Industries Ltd. (India)
  • GlaxoSmithKline plc (U.K.)
  • Unichem Laboratories Ltd. (India)
  • Zydus Cadila (India)
  • Prestium Pharma, Inc. (U.S.)